Stay updated with breaking news from Rizal provincial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Globe aids Antipolo's pandemic response through Free GoWiFi and AMBER – Manila Bulletin mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
Published March 12, 2021, 3:45 PM Majority of the medical frontliners in a public hospital in Binangonan who were inoculated with the COVID-19 vaccine preferred the European-made AstraZeneca vaccine versus China’s Sinovac. Dr. Esterio Ibe Jr., medical officer at the Margarito A. Duavit Memorial Hospital or Rizal Provincial Hospital System (RPHS) Binangonan Annex, said out of the more than 100 who were lined up during the first batch of the inoculation, only seven chose the Sinovac vaccine as against the European-made AstraZeneca vaccine. Lalawigan ng Rizal Facebook page / MANILA BULLETIN The Rizal Provincial government said 133 vaccines were allocated by the Department of Health for the initial vaccine rollout at the RPHS Binangonan Annex on March 12. The vaccination will be done for two days. ....
Published January 14, 2021, 10:11 AM The municipal government of Cainta has assured free immunization against COVID-19 for all its residents after it entered into an agreement with a British-Swedish pharmaceutical company for the purchase of vaccines. In his post on Facebook, Mayor Johnielle Keith Nieto said the municipal government has signed a confidentiality agreement with AstraZeneca in relation to the possible supply of AZD 1222 or the Oxford AstraZeneca vaccine. Nieto also announced that they are also in talks with another vaccine manufacturer based in China “to ensure adequate supply for the people of Cainta.” The local chief executive had earlier said that P150 million has been initially allocated for the procurement of the vaccines which will be given for free to Cainta residents. ....